APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Medical Polymers

The medical polymers market comprises resins and fibers, elastomers and biodegradable plastics that are used in various healthcare applications such as equipment and devices, packaging and tissue engineering. Polyvinyl chloride, polypropylene, polystyrene and polyethylene are the commonly used fibers and resins in the medical industry.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

The medical polymers market comprises resins and fibers, elastomers and biodegradable plastics that are used in various healthcare applications such as equipment and devices, packaging and tissue engineering. Polyvinyl chloride, polypropylene, polystyrene and polyethylene are the commonly used fibers and resins in the medical industry.

Selected research

Market Structure

Global Medical Polymers Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 17391401032 January 2026193 pages

Choose your research edition.

Industry ResearchMedical Polymers Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Medical Polymers Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Medical Polymers Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medical Polymers Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Medical Polymers Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The medical polymers market comprises resins and fibers, elastomers and biodegradable plastics that are used in various healthcare applications such as equipment and devices, packaging and tissue engineering. Polyvinyl chloride, polypropylene, polystyrene and polyethylene are the commonly used fibers and resins in the medical industry.

The major players in global Medical Polymers market include BASF SE, Bayer, Celanese, DSM, Du Pont, etc. The top 5 players occupy about 20% shares of the global market. Europe and North America are main markets, they occupy over 60% of the global market. Medical Resins and Fibers is the main type, with a share about 80%. Medical Packaging is the main application, which holds a share about 50%.

This report provides an overview of the global Medical Polymers market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Medical Polymers and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Medical Polymers sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Medical Polymers market size, projected growth trends, production technologies, key applications, and end-use industries.

Medical Polymers Segment by Company

BASF SE

Bayer

Celanese

DSM

DuPont

Solvay

Eastman Chemical

Evonik

HEXPOL

Exxon Mobil

Formosa Plastics

INEOS

Victrex

Colorite Compounds

Raumedic

Kraton

Tianjin Plastics

Shanghai New Shanghua

Medical Polymers Segment by Type

Medical Resins and Fibers

Medical Elastomers

Biodegradable Plastics

Other

Medical Polymers Segment by Application

Medical Devices and Equipment

Medical Packaging

Others (Including Tissue Engineering and Cardio Stents)

Medical Polymers Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Polymers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Polymers and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Polymers.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Medical Polymers market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Medical Polymers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Medical Polymers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Medical Polymers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Medical Polymers Industry Trends Table 2. Medical Polymers Industry Drivers Table 3. Medical Polymers Industry Opportunities and Challenges Table 4. Medical Polymers Industry Restraints Table 5. Global Medical Polymers Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Medical Polymers Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Medical Polymers Sales by Manufacturers (kt) & (2021-2026) Table 8. Global Medical Polymers Sales Market Share by Manufacturers Table 9. Global Medical Polymers Average Sales Price (US$/t) of Manufacturers (2021-2026) Table 10. Global Medical Polymers Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Medical Polymers Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Medical Polymers Manufacturers, Product Type & Application Table 13. Global Medical Polymers Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Medical Polymers by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Medical Resins and Fibers Table 17. Major Manufacturers of Medical Elastomers Table 18. Major Manufacturers of Biodegradable Plastics Table 19. Major Manufacturers of Other Table 20. Global Medical Polymers Sales by Type 2021 VS 2025 VS 2032 (kt) Table 21. Global Medical Polymers Sales by Type (2021-2026) & (kt) Table 22. Global Medical Polymers Sales by Type (2027-2032) & (kt) Table 23. Global Medical Polymers Sales Market Share by Type (2021-2026) Table 24. Global Medical Polymers Sales Market Share by Type (2027-2032) Table 25. Global Medical Polymers Revenue by Type 2021 VS 2025 VS 2032 (kt) Table 26. Global Medical Polymers Revenue by Type (2021-2026) & (kt) Table 27. Global Medical Polymers Revenue by Type (2027-2032) & (kt) Table 28. Global Medical Polymers Revenue Market Share by Type (2021-2026) Table 29. Global Medical Polymers Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Medical Devices and Equipment Table 31. Major Manufacturers of Medical Packaging Table 32. Major Manufacturers of Others (Including Tissue Engineering and Cardio Stents) Table 33. Global Medical Polymers Sales by Application 2021 VS 2025 VS 2032 (kt) Table 34. Global Medical Polymers Sales by Application (2021-2026) & (kt) Table 35. Global Medical Polymers Sales by Application (2027-2032) & (kt) Table 36. Global Medical Polymers Sales Market Share by Application (2021-2026) Table 37. Global Medical Polymers Sales Market Share by Application (2027-2032) Table 38. Global Medical Polymers Revenue by Application 2021 VS 2025 VS 2032 (kt) Table 39. Global Medical Polymers Revenue by Application (2021-2026) & (kt) Table 40. Global Medical Polymers Revenue by Application (2027-2032) & (kt) Table 41. Global Medical Polymers Revenue Market Share by Application (2021-2026) Table 42. Global Medical Polymers Revenue Market Share by Application (2027-2032) Table 43. Global Medical Polymers Sales by Region: 2021 VS 2025 VS 2032 (kt) Table 44. Global Medical Polymers Sales by Region (2021-2026) & (kt) Table 45. Global Medical Polymers Sales Market Share by Region (2021-2026) Table 46. Global Medical Polymers Sales Forecasted by Region (2027-2032) & (kt) Table 47. Global Medical Polymers Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Medical Polymers Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kt) Table 49. North America Medical Polymers Sales by Country (2021-2026) & (kt) Table 50. North America Medical Polymers Sales by Country (2027-2032) & (kt) Table 51. Europe Medical Polymers Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kt) Table 52. Europe Medical Polymers Sales by Country (2021-2026) & (kt) Table 53. Europe Medical Polymers Sales by Country (2027-2032) & (kt) Table 54. Asia Pacific Medical Polymers Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kt) Table 55. Asia Pacific Medical Polymers Sales by Country (2021-2026) & (kt) Table 56. Asia Pacific Medical Polymers Sales by Country (2027-2032) & (kt) Table 57. South America, Middle East and Africa Medical Polymers Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kt) Table 58. South America, Middle East and Africa Medical Polymers Sales by Country (2021-2026) & (kt) Table 59. South America, Middle East and Africa Medical Polymers Sales by Country (2027-2032) & (kt) Table 60. Global Medical Polymers Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Medical Polymers Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Medical Polymers Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Medical Polymers Revenue Market Share by Region (2021-2026) Table 64. Global Medical Polymers Revenue Market Share by Region (2027-2032) Table 65. BASF SE Company Information Table 66. BASF SE Business Overview Table 67. BASF SE Medical Polymers Sales (kt), Price (US$/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. BASF SE Medical Polymers Product Portfolio Table 69. BASF SE Recent Development Table 70. Bayer Company Information Table 71. Bayer Business Overview Table 72. Bayer Medical Polymers Sales (kt), Price (US$/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Bayer Medical Polymers Product Portfolio Table 74. Bayer Recent Development Table 75. Celanese Company Information Table 76. Celanese Business Overview Table 77. Celanese Medical Polymers Sales (kt), Price (US$/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Celanese Medical Polymers Product Portfolio Table 79. Celanese Recent Development Table 80. DSM Company Information Table 81. DSM Business Overview Table 82. DSM Medical Polymers Sales (kt), Price (US$/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. DSM Medical Polymers Product Portfolio Table 84. DSM Recent Development Table 85. DuPont Company Information Table 86. DuPont Business Overview Table 87. DuPont Medical Polymers Sales (kt), Price (US$/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. DuPont Medical Polymers Product Portfolio Table 89. DuPont Recent Development Table 90. Solvay Company Information Table 91. Solvay Business Overview Table 92. Solvay Medical Polymers Sales (kt), Price (US$/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Solvay Medical Polymers Product Portfolio Table 94. Solvay Recent Development Table 95. Eastman Chemical Company Information Table 96. Eastman Chemical Business Overview Table 97. Eastman Chemical Medical Polymers Sales (kt), Price (US$/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Eastman Chemical Medical Polymers Product Portfolio Table 99. Eastman Chemical Recent Development Table 100. Evonik Company Information Table 101. Evonik Business Overview Table 102. Evonik Medical Polymers Sales (kt), Price (US$/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Evonik Medical Polymers Product Portfolio Table 104. Evonik Recent Development Table 105. HEXPOL Company Information Table 106. HEXPOL Business Overview Table 107. HEXPOL Medical Polymers Sales (kt), Price (US$/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. HEXPOL Medical Polymers Product Portfolio Table 109. HEXPOL Recent Development Table 110. Exxon Mobil Company Information Table 111. Exxon Mobil Business Overview Table 112. Exxon Mobil Medical Polymers Sales (kt), Price (US$/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Exxon Mobil Medical Polymers Product Portfolio Table 114. Exxon Mobil Recent Development Table 115. Formosa Plastics Company Information Table 116. Formosa Plastics Business Overview Table 117. Formosa Plastics Medical Polymers Sales (kt), Price (US$/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Formosa Plastics Medical Polymers Product Portfolio Table 119. Formosa Plastics Recent Development Table 120. INEOS Company Information Table 121. INEOS Business Overview Table 122. INEOS Medical Polymers Sales (kt), Price (US$/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. INEOS Medical Polymers Product Portfolio Table 124. INEOS Recent Development Table 125. Victrex Company Information Table 126. Victrex Business Overview Table 127. Victrex Medical Polymers Sales (kt), Price (US$/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Victrex Medical Polymers Product Portfolio Table 129. Victrex Recent Development Table 130. Colorite Compounds Company Information Table 131. Colorite Compounds Business Overview Table 132. Colorite Compounds Medical Polymers Sales (kt), Price (US$/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Colorite Compounds Medical Polymers Product Portfolio Table 134. Colorite Compounds Recent Development Table 135. Raumedic Company Information Table 136. Raumedic Business Overview Table 137. Raumedic Medical Polymers Sales (kt), Price (US$/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. Raumedic Medical Polymers Product Portfolio Table 139. Raumedic Recent Development Table 140. Kraton Company Information Table 141. Kraton Business Overview Table 142. Kraton Medical Polymers Sales (kt), Price (US$/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 143. Kraton Medical Polymers Product Portfolio Table 144. Kraton Recent Development Table 145. Tianjin Plastics Company Information Table 146. Tianjin Plastics Business Overview Table 147. Tianjin Plastics Medical Polymers Sales (kt), Price (US$/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 148. Tianjin Plastics Medical Polymers Product Portfolio Table 149. Tianjin Plastics Recent Development Table 150. Shanghai New Shanghua Company Information Table 151. Shanghai New Shanghua Business Overview Table 152. Shanghai New Shanghua Medical Polymers Sales (kt), Price (US$/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 153. Shanghai New Shanghua Medical Polymers Product Portfolio Table 154. Shanghai New Shanghua Recent Development Table 155. Key Raw Materials Table 156. Raw Materials Key Suppliers Table 157. Medical Polymers Distributors List Table 158. Medical Polymers Customers List Table 159. Research Programs/Design for This Report Table 160. Authors List of This Report Table 161. Secondary Sources Table 162. Primary Sources List of Figures Figure 1. Medical Polymers Product Image Figure 2. Global Medical Polymers Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medical Polymers Market Size (2021-2032) & (US$ Million) Figure 4. Global Medical Polymers Sales (2021-2032) & (kt) Figure 5. Global Medical Polymers Average Price (US$/t) & (2021-2032) Figure 6. Global Top 5 and 10 Medical Polymers Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Medical Resins and Fibers Image Figure 9. Medical Elastomers Image Figure 10. Biodegradable Plastics Image Figure 11. Other Image Figure 12. Global Medical Polymers Sales by Type (2021 VS 2025 VS 2032) & (kt) Figure 13. Global Medical Polymers Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Medical Polymers Sales Market Share by Type (2021-2032) Figure 15. Global Medical Polymers Revenue by Type (2021 VS 2025 VS 2032) & (kt) Figure 16. Global Medical Polymers Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Medical Polymers Revenue Market Share by Type (2021-2032) Figure 18. Medical Devices and Equipment Image Figure 19. Medical Packaging Image Figure 20. Others (Including Tissue Engineering and Cardio Stents) Image Figure 21. Global Medical Polymers Sales by Application (2021 VS 2025 VS 2032) & (kt) Figure 22. Global Medical Polymers Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Medical Polymers Sales Market Share by Application (2021-2032) Figure 24. Global Medical Polymers Revenue by Application (2021 VS 2025 VS 2032) & (kt) Figure 25. Global Medical Polymers Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Medical Polymers Revenue Market Share by Application (2021-2032) Figure 27. North America Medical Polymers Sales and Growth Rate (2021-2032) & (kt) Figure 28. North America Medical Polymers Sales Market Share by Country (2021-2032) Figure 29. U.S. Medical Polymers Sales and Growth Rate (2021-2032) & (kt) Figure 30. Canada Medical Polymers Sales and Growth Rate (2021-2032) & (kt) Figure 31. Mexico Medical Polymers Sales and Growth Rate (2021-2032) & (kt) Figure 32. Europe Medical Polymers Sales and Growth Rate (2021-2032) & (kt) Figure 33. Europe Medical Polymers Sales Market Share by Country (2021-2032) Figure 34. Germany Medical Polymers Sales and Growth Rate (2021-2032) & (kt) Figure 35. France Medical Polymers Sales and Growth Rate (2021-2032) & (kt) Figure 36. U.K. Medical Polymers Sales and Growth Rate (2021-2032) & (kt) Figure 37. Italy Medical Polymers Sales and Growth Rate (2021-2032) & (kt) Figure 38. Netherlands Medical Polymers Sales and Growth Rate (2021-2032) & (kt) Figure 39. Asia Pacific Medical Polymers Sales and Growth Rate (2021-2032) & (kt) Figure 40. Asia Pacific Medical Polymers Sales Market Share by Country (2021-2032) Figure 41. China Medical Polymers Sales and Growth Rate (2021-2032) & (kt) Figure 42. Japan Medical Polymers Sales and Growth Rate (2021-2032) & (kt) Figure 43. South Korea Medical Polymers Sales and Growth Rate (2021-2032) & (kt) Figure 44. Southeast Asia Medical Polymers Sales and Growth Rate (2021-2032) & (kt) Figure 45. India Medical Polymers Sales and Growth Rate (2021-2032) & (kt) Figure 46. Australia Medical Polymers Sales and Growth Rate (2021-2032) & (kt) Figure 47. South America, Middle East and Africa Medical Polymers Sales and Growth Rate (2021-2032) & (kt) Figure 48. South America, Middle East and Africa Medical Polymers Sales Market Share by Country (2021-2032) Figure 49. Brazil Medical Polymers Sales and Growth Rate (2021-2032) & (kt) Figure 50. South Africa Medical Polymers Sales and Growth Rate (2021-2032) & (kt) Figure 51. Saudi Arabia Medical Polymers Sales and Growth Rate (2021-2032) & (kt) Figure 52. Turkey Medical Polymers Sales and Growth Rate (2021-2032) & (kt) Figure 53. Argentina Medical Polymers Sales and Growth Rate (2021-2032) & (kt) Figure 54. UAE Medical Polymers Sales and Growth Rate (2021-2032) & (kt) Figure 55. Egypt Medical Polymers Sales and Growth Rate (2021-2032) & (kt) Figure 56. Chile Medical Polymers Sales and Growth Rate (2021-2032) & (kt) Figure 57. Global Medical Polymers Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Medical Polymers Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Medical Polymers Revenue (2021-2032) & (US$ Million) Figure 60. North America Medical Polymers Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Medical Polymers Revenue (2021-2032) & (US$ Million) Figure 62. Europe Medical Polymers Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Medical Polymers Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Medical Polymers Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Medical Polymers Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Medical Polymers Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Medical Polymers Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Medical Polymers Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Medical Resins and Fibers
  • Medical Elastomers
  • Biodegradable Plastics
  • Other
Applications
  • Medical Devices and Equipment
  • Medical Packaging
  • Others (Including Tissue Engineering and Cardio Stents)
Companies covered
  • BASF SE
  • Bayer
  • Celanese
  • DSM
  • DuPont
  • Solvay
  • Eastman Chemical
  • Evonik
  • HEXPOL
  • Exxon Mobil
  • Formosa Plastics
  • INEOS
  • Victrex
  • Colorite Compounds
  • Raumedic
  • Kraton
  • Tianjin Plastics
  • Shanghai New Shanghua

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Medical Polymers Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Medical Polymers Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Medical Polymers Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Medical Polymers Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Medical Polymers Market Dynamics
  1. 2.1 Medical Polymers Industry Trends
  2. 2.2 Medical Polymers Industry Drivers
  3. 2.3 Medical Polymers Industry Opportunities and Challenges
  4. 2.4 Medical Polymers Industry Restraints
3 Medical Polymers Market by Manufacturers
  1. 3.1 Global Medical Polymers Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Medical Polymers Sales by Manufacturers (2021-2026)
  3. 3.3 Global Medical Polymers Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Medical Polymers Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Medical Polymers Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Medical Polymers Manufacturers, Product Type & Application
  7. 3.7 Global Medical Polymers Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Medical Polymers Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Medical Polymers Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Medical Polymers Tier 1, Tier 2, and Tier 3
4 Medical Polymers Market by Type
  1. 4.1 Medical Polymers Type Introduction
  2. 4.1.1 Medical Resins and Fibers
  3. 4.1.2 Medical Elastomers
  4. 4.1.3 Biodegradable Plastics
  5. 4.1.4 Other
  6. 4.2 Global Medical Polymers Sales by Type
  7. 4.2.1 Global Medical Polymers Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Medical Polymers Sales by Type (2021-2032)
  9. 4.2.3 Global Medical Polymers Sales Market Share by Type (2021-2032)
  10. 4.3 Global Medical Polymers Revenue by Type
  11. 4.3.1 Global Medical Polymers Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Medical Polymers Revenue by Type (2021-2032)
  13. 4.3.3 Global Medical Polymers Revenue Market Share by Type (2021-2032)
5 Medical Polymers Market by Application
  1. 5.1 Medical Polymers Application Introduction
  2. 5.1.1 Medical Devices and Equipment
  3. 5.1.2 Medical Packaging
  4. 5.1.3 Others (Including Tissue Engineering and Cardio Stents)
  5. 5.2 Global Medical Polymers Sales by Application
  6. 5.2.1 Global Medical Polymers Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Medical Polymers Sales by Application (2021-2032)
  8. 5.2.3 Global Medical Polymers Sales Market Share by Application (2021-2032)
  9. 5.3 Global Medical Polymers Revenue by Application
  10. 5.3.1 Global Medical Polymers Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Medical Polymers Revenue by Application (2021-2032)
  12. 5.3.3 Global Medical Polymers Revenue Market Share by Application (2021-2032)
6 Global Medical Polymers Sales by Region
  1. 6.1 Global Medical Polymers Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Medical Polymers Sales by Region (2021-2032)
  3. 6.2.1 Global Medical Polymers Sales by Region (2021-2026)
  4. 6.2.2 Global Medical Polymers Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Medical Polymers Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Medical Polymers Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Medical Polymers Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Medical Polymers Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Medical Polymers Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Medical Polymers Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Medical Polymers Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Medical Polymers Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Medical Polymers Revenue by Region
  1. 7.1 Global Medical Polymers Revenue by Region
  2. 7.1.1 Global Medical Polymers Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Medical Polymers Revenue by Region (2021-2026)
  4. 7.1.3 Global Medical Polymers Revenue by Region (2027-2032)
  5. 7.1.4 Global Medical Polymers Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Medical Polymers Revenue (2021-2032)
  8. 7.2.2 North America Medical Polymers Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Medical Polymers Revenue (2021-2032)
  11. 7.3.2 Europe Medical Polymers Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Medical Polymers Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Medical Polymers Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Medical Polymers Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Medical Polymers Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 BASF SE
  2. 8.1.1 BASF SE Company Information
  3. 8.1.2 BASF SE Business Overview
  4. 8.1.3 BASF SE Medical Polymers Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 BASF SE Medical Polymers Product Portfolio
  6. 8.1.5 BASF SE Recent Developments
  7. 8.2 Bayer
  8. 8.2.1 Bayer Company Information
  9. 8.2.2 Bayer Business Overview
  10. 8.2.3 Bayer Medical Polymers Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bayer Medical Polymers Product Portfolio
  12. 8.2.5 Bayer Recent Developments
  13. 8.3 Celanese
  14. 8.3.1 Celanese Company Information
  15. 8.3.2 Celanese Business Overview
  16. 8.3.3 Celanese Medical Polymers Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Celanese Medical Polymers Product Portfolio
  18. 8.3.5 Celanese Recent Developments
  19. 8.4 DSM
  20. 8.4.1 DSM Company Information
  21. 8.4.2 DSM Business Overview
  22. 8.4.3 DSM Medical Polymers Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 DSM Medical Polymers Product Portfolio
  24. 8.4.5 DSM Recent Developments
  25. 8.5 DuPont
  26. 8.5.1 DuPont Company Information
  27. 8.5.2 DuPont Business Overview
  28. 8.5.3 DuPont Medical Polymers Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 DuPont Medical Polymers Product Portfolio
  30. 8.5.5 DuPont Recent Developments
  31. 8.6 Solvay
  32. 8.6.1 Solvay Company Information
  33. 8.6.2 Solvay Business Overview
  34. 8.6.3 Solvay Medical Polymers Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Solvay Medical Polymers Product Portfolio
  36. 8.6.5 Solvay Recent Developments
  37. 8.7 Eastman Chemical
  38. 8.7.1 Eastman Chemical Company Information
  39. 8.7.2 Eastman Chemical Business Overview
  40. 8.7.3 Eastman Chemical Medical Polymers Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Eastman Chemical Medical Polymers Product Portfolio
  42. 8.7.5 Eastman Chemical Recent Developments
  43. 8.8 Evonik
  44. 8.8.1 Evonik Company Information
  45. 8.8.2 Evonik Business Overview
  46. 8.8.3 Evonik Medical Polymers Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Evonik Medical Polymers Product Portfolio
  48. 8.8.5 Evonik Recent Developments
  49. 8.9 HEXPOL
  50. 8.9.1 HEXPOL Company Information
  51. 8.9.2 HEXPOL Business Overview
  52. 8.9.3 HEXPOL Medical Polymers Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 HEXPOL Medical Polymers Product Portfolio
  54. 8.9.5 HEXPOL Recent Developments
  55. 8.10 Exxon Mobil
  56. 8.10.1 Exxon Mobil Company Information
  57. 8.10.2 Exxon Mobil Business Overview
  58. 8.10.3 Exxon Mobil Medical Polymers Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Exxon Mobil Medical Polymers Product Portfolio
  60. 8.10.5 Exxon Mobil Recent Developments
  61. 8.11 Formosa Plastics
  62. 8.11.1 Formosa Plastics Company Information
  63. 8.11.2 Formosa Plastics Business Overview
  64. 8.11.3 Formosa Plastics Medical Polymers Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Formosa Plastics Medical Polymers Product Portfolio
  66. 8.11.5 Formosa Plastics Recent Developments
  67. 8.12 INEOS
  68. 8.12.1 INEOS Company Information
  69. 8.12.2 INEOS Business Overview
  70. 8.12.3 INEOS Medical Polymers Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 INEOS Medical Polymers Product Portfolio
  72. 8.12.5 INEOS Recent Developments
  73. 8.13 Victrex
  74. 8.13.1 Victrex Company Information
  75. 8.13.2 Victrex Business Overview
  76. 8.13.3 Victrex Medical Polymers Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Victrex Medical Polymers Product Portfolio
  78. 8.13.5 Victrex Recent Developments
  79. 8.14 Colorite Compounds
  80. 8.14.1 Colorite Compounds Company Information
  81. 8.14.2 Colorite Compounds Business Overview
  82. 8.14.3 Colorite Compounds Medical Polymers Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Colorite Compounds Medical Polymers Product Portfolio
  84. 8.14.5 Colorite Compounds Recent Developments
  85. 8.15 Raumedic
  86. 8.15.1 Raumedic Company Information
  87. 8.15.2 Raumedic Business Overview
  88. 8.15.3 Raumedic Medical Polymers Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Raumedic Medical Polymers Product Portfolio
  90. 8.15.5 Raumedic Recent Developments
  91. 8.16 Kraton
  92. 8.16.1 Kraton Company Information
  93. 8.16.2 Kraton Business Overview
  94. 8.16.3 Kraton Medical Polymers Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Kraton Medical Polymers Product Portfolio
  96. 8.16.5 Kraton Recent Developments
  97. 8.17 Tianjin Plastics
  98. 8.17.1 Tianjin Plastics Company Information
  99. 8.17.2 Tianjin Plastics Business Overview
  100. 8.17.3 Tianjin Plastics Medical Polymers Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Tianjin Plastics Medical Polymers Product Portfolio
  102. 8.17.5 Tianjin Plastics Recent Developments
  103. 8.18 Shanghai New Shanghua
  104. 8.18.1 Shanghai New Shanghua Company Information
  105. 8.18.2 Shanghai New Shanghua Business Overview
  106. 8.18.3 Shanghai New Shanghua Medical Polymers Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Shanghai New Shanghua Medical Polymers Product Portfolio
  108. 8.18.5 Shanghai New Shanghua Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Medical Polymers Value Chain Analysis
  2. 9.1.1 Medical Polymers Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Medical Polymers Production Mode & Process
  6. 9.2 Medical Polymers Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Medical Polymers Distributors
  9. 9.2.3 Medical Polymers Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst